nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—colon cancer—Betamethasone—atopic dermatitis	0.197	0.366	CpDpCtD
Aprepitant—colon cancer—Dexamethasone—atopic dermatitis	0.197	0.366	CpDpCtD
Aprepitant—breast cancer—Dexamethasone—atopic dermatitis	0.0723	0.134	CpDpCtD
Aprepitant—breast cancer—Betamethasone—atopic dermatitis	0.0723	0.134	CpDpCtD
Aprepitant—CYP3A7—Tacrolimus—atopic dermatitis	0.0338	0.111	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0338	0.111	CbGbCtD
Aprepitant—CYP3A5—Tacrolimus—atopic dermatitis	0.0254	0.0831	CbGbCtD
Aprepitant—CYP3A4—Pimecrolimus—atopic dermatitis	0.0166	0.0545	CbGbCtD
Aprepitant—CYP2C19—Loratadine—atopic dermatitis	0.015	0.0491	CbGbCtD
Aprepitant—CYP2C19—Diphenhydramine—atopic dermatitis	0.015	0.0491	CbGbCtD
Aprepitant—CYP1A2—Diphenhydramine—atopic dermatitis	0.0138	0.0453	CbGbCtD
Aprepitant—CYP3A7—Hydrocortisone—atopic dermatitis	0.0138	0.0451	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0138	0.0451	CbGbCtD
Aprepitant—CYP2C9—Loratadine—atopic dermatitis	0.0124	0.0408	CbGbCtD
Aprepitant—CYP2C9—Diphenhydramine—atopic dermatitis	0.0124	0.0408	CbGbCtD
Aprepitant—CYP3A5—Hydrocortisone—atopic dermatitis	0.0103	0.0338	CbGbCtD
Aprepitant—CYP3A4—Tacrolimus—atopic dermatitis	0.00989	0.0324	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.00856	0.028	CbGbCtD
Aprepitant—CYP3A7—Dexamethasone—atopic dermatitis	0.00856	0.028	CbGbCtD
Aprepitant—CYP2C19—Prednisone—atopic dermatitis	0.00829	0.0272	CbGbCtD
Aprepitant—TACR3—Tachykinin receptors bind tachykinins—TAC1—atopic dermatitis	0.00826	0.167	CbGpPWpGaD
Aprepitant—CYP3A4—Loratadine—atopic dermatitis	0.00724	0.0237	CbGbCtD
Aprepitant—CYP3A4—Methylprednisolone—atopic dermatitis	0.00662	0.0217	CbGbCtD
Aprepitant—CYP3A5—Dexamethasone—atopic dermatitis	0.00642	0.021	CbGbCtD
Aprepitant—CYP2C19—Dexamethasone—atopic dermatitis	0.00518	0.017	CbGbCtD
Aprepitant—CYP3A4—Triamcinolone—atopic dermatitis	0.00502	0.0164	CbGbCtD
Aprepitant—CYP2C9—Dexamethasone—atopic dermatitis	0.0043	0.0141	CbGbCtD
Aprepitant—CYP3A4—Betamethasone—atopic dermatitis	0.0043	0.0141	CbGbCtD
Aprepitant—CYP3A4—Prednisolone—atopic dermatitis	0.00425	0.0139	CbGbCtD
Aprepitant—TACR1—Tachykinin receptors bind tachykinins—TAC1—atopic dermatitis	0.00403	0.0816	CbGpPWpGaD
Aprepitant—CYP3A4—Hydrocortisone—atopic dermatitis	0.00402	0.0132	CbGbCtD
Aprepitant—CYP3A4—Prednisone—atopic dermatitis	0.00401	0.0131	CbGbCtD
Aprepitant—CYP3A4—Dexamethasone—atopic dermatitis	0.0025	0.0082	CbGbCtD
Aprepitant—TACR3—Peptide GPCRs—CCR3—atopic dermatitis	0.00107	0.0217	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000961	0.0194	CbGpPWpGaD
Aprepitant—TACR3—Peptide GPCRs—CXCR3—atopic dermatitis	0.000938	0.019	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000856	0.0173	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000768	0.0155	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000644	0.013	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000619	0.0125	CbGpPWpGaD
Aprepitant—TACR3—Peptide GPCRs—CCR5—atopic dermatitis	0.000588	0.0119	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000574	0.0116	CbGpPWpGaD
Aprepitant—TACR1—Peptide GPCRs—CCR3—atopic dermatitis	0.000524	0.0106	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000515	0.0104	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000505	0.0102	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL22—atopic dermatitis	0.000491	0.00993	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.000469	0.0095	CbGpPWpGaD
Aprepitant—TACR1—Peptide GPCRs—CXCR3—atopic dermatitis	0.000458	0.00927	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—NPS—atopic dermatitis	0.000456	0.00922	CbGpPWpGaD
Aprepitant—TACR3—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000456	0.00922	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00045	0.00911	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00045	0.00911	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000441	0.00893	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL27—atopic dermatitis	0.000437	0.00885	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.000418	0.00846	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000415	0.00841	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000407	0.00825	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000407	0.00825	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL17—atopic dermatitis	0.000392	0.00794	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.000375	0.00759	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000357	0.00722	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000339	0.00685	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL11—atopic dermatitis	0.000316	0.0064	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.000315	0.00637	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000307	0.00621	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.000302	0.00612	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000302	0.00611	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000302	0.00611	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000296	0.00599	CbGpPWpGaD
Aprepitant—TACR1—Peptide GPCRs—CCR5—atopic dermatitis	0.000287	0.00581	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.000281	0.00568	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.000279	0.00566	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000277	0.0056	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCR3—atopic dermatitis	0.000258	0.00522	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.000257	0.00521	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000255	0.00516	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL22—atopic dermatitis	0.000252	0.0051	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.000252	0.00509	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCL27—atopic dermatitis	0.000247	0.005	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.000246	0.00499	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL22—atopic dermatitis	0.00024	0.00485	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000239	0.00484	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—TAC1—atopic dermatitis	0.00023	0.00465	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—NPS—atopic dermatitis	0.00023	0.00465	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—BDNF—atopic dermatitis	0.000229	0.00463	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CXCR3—atopic dermatitis	0.000225	0.00456	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL27—atopic dermatitis	0.000224	0.00454	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000222	0.0045	CbGpPWpGaD
Aprepitant—TACR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.000222	0.0045	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00022	0.00445	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00022	0.00445	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000215	0.00436	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL27—atopic dermatitis	0.000214	0.00432	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL4—atopic dermatitis	0.000213	0.0043	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000206	0.00417	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000203	0.00411	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL17—atopic dermatitis	0.000201	0.00408	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000199	0.00403	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000199	0.00403	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL17—atopic dermatitis	0.000192	0.00388	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000185	0.00375	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.000183	0.00371	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CXCL10—atopic dermatitis	0.000182	0.00369	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.000175	0.00354	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000174	0.00352	CbGpPWpGaD
Aprepitant—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000173	0.0035	CbGpPWpGaD
Aprepitant—TACR3—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.000167	0.00338	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000165	0.00335	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.000163	0.00329	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL11—atopic dermatitis	0.000162	0.00328	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—FCER2—atopic dermatitis	0.00016	0.00324	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCL5—atopic dermatitis	0.000157	0.00317	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL11—atopic dermatitis	0.000154	0.00313	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00015	0.00303	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL22—atopic dermatitis	0.000149	0.00301	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000147	0.00298	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000147	0.00298	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCR3—atopic dermatitis	0.000146	0.00295	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000145	0.00292	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CCR5—atopic dermatitis	0.000141	0.00286	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000135	0.00273	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL27—atopic dermatitis	0.000133	0.00268	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCR3—atopic dermatitis	0.000132	0.00268	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—NPS—atopic dermatitis	0.00013	0.00263	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—TAC1—atopic dermatitis	0.00013	0.00263	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IFNG—atopic dermatitis	0.000129	0.0026	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000127	0.00258	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCR3—atopic dermatitis	0.000126	0.00255	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL22—atopic dermatitis	0.000123	0.00249	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000121	0.00244	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—IL5—atopic dermatitis	0.000121	0.00244	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—CXCL8—atopic dermatitis	0.00012	0.00242	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL17—atopic dermatitis	0.000119	0.00241	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—TAC1—atopic dermatitis	0.000118	0.00239	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—NPS—atopic dermatitis	0.000118	0.00239	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000117	0.00236	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CXCR3—atopic dermatitis	0.000116	0.00234	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL1B—atopic dermatitis	0.000115	0.00232	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL2—atopic dermatitis	0.000114	0.00231	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—TAC1—atopic dermatitis	0.000112	0.00227	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—NPS—atopic dermatitis	0.000112	0.00227	CbGpPWpGaD
Aprepitant—TACR3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000112	0.00227	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00011	0.00223	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL5—atopic dermatitis	0.00011	0.00222	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL27—atopic dermatitis	0.00011	0.00222	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—KIF3A—atopic dermatitis	0.000106	0.00215	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000103	0.00208	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000101	0.00204	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL17—atopic dermatitis	9.83e-05	0.00199	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCL11—atopic dermatitis	9.59e-05	0.00194	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CMA1—atopic dermatitis	9.59e-05	0.00194	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	9.56e-05	0.00194	CbGpPWpGaD
Aprepitant—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	9.38e-05	0.0019	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CXCL10—atopic dermatitis	9.35e-05	0.00189	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	9.17e-05	0.00186	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.06e-05	0.00183	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—STAT6—atopic dermatitis	9.01e-05	0.00182	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CXCL10—atopic dermatitis	8.89e-05	0.0018	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCL5—atopic dermatitis	8.86e-05	0.00179	CbGpPWpGaD
Aprepitant—TACR3—GPCR ligand binding—CXCL8—atopic dermatitis	8.54e-05	0.00173	CbGpPWpGaD
Aprepitant—TACR3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	8.51e-05	0.00172	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—TNF—atopic dermatitis	8.32e-05	0.00168	CbGpPWpGaD
Aprepitant—TACR1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	8.16e-05	0.00165	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCL5—atopic dermatitis	8.05e-05	0.00163	CbGpPWpGaD
Aprepitant—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	8.02e-05	0.00162	CbGpPWpGaD
Aprepitant—TACR3—GPCR downstream signaling—CCR5—atopic dermatitis	7.98e-05	0.00162	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCL11—atopic dermatitis	7.93e-05	0.0016	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—FCER2—atopic dermatitis	7.82e-05	0.00158	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CCR3—atopic dermatitis	7.82e-05	0.00158	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCL5—atopic dermatitis	7.66e-05	0.00155	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL22—atopic dermatitis	7.27e-05	0.00147	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—CCR5—atopic dermatitis	7.25e-05	0.00147	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCR3—atopic dermatitis	7.11e-05	0.00144	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—TAC1—atopic dermatitis	6.97e-05	0.00141	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—NPS—atopic dermatitis	6.97e-05	0.00141	CbGpPWpGaD
Aprepitant—TACR1—GPCR ligand binding—CCR5—atopic dermatitis	6.9e-05	0.0014	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCR3—atopic dermatitis	6.83e-05	0.00138	CbGpPWpGaD
Aprepitant—TACR1—Spinal Cord Injury—IL6—atopic dermatitis	6.71e-05	0.00136	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—TNF—atopic dermatitis	6.65e-05	0.00135	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL5—atopic dermatitis	6.48e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL27—atopic dermatitis	6.48e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CCR3—atopic dermatitis	6.46e-05	0.00131	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—NPS—atopic dermatitis	6.34e-05	0.00128	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—TAC1—atopic dermatitis	6.34e-05	0.00128	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.22e-05	0.00126	CbGpPWpGaD
Aprepitant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.19e-05	0.00125	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—IL5—atopic dermatitis	5.9e-05	0.00119	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL17—atopic dermatitis	5.81e-05	0.00118	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—NPS—atopic dermatitis	5.76e-05	0.00117	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—TAC1—atopic dermatitis	5.76e-05	0.00117	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCR3—atopic dermatitis	5.65e-05	0.00114	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL10—atopic dermatitis	5.52e-05	0.00112	CbGpPWpGaD
Aprepitant—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.48e-05	0.00111	CbGpPWpGaD
Aprepitant—TACR1—SIDS Susceptibility Pathways—IL6—atopic dermatitis	5.37e-05	0.00109	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL5—atopic dermatitis	5.35e-05	0.00108	CbGpPWpGaD
Aprepitant—Cough—Triamcinolone—atopic dermatitis	5.19e-05	0.000484	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—KIF3A—atopic dermatitis	5.18e-05	0.00105	CbGpPWpGaD
Aprepitant—Headache—Tacrolimus—atopic dermatitis	5.17e-05	0.000483	CcSEcCtD
Aprepitant—Anaphylactic shock—Hydrocortisone—atopic dermatitis	5.15e-05	0.000481	CcSEcCtD
Aprepitant—Oedema—Hydrocortisone—atopic dermatitis	5.15e-05	0.000481	CcSEcCtD
Aprepitant—Convulsion—Triamcinolone—atopic dermatitis	5.15e-05	0.000481	CcSEcCtD
Aprepitant—Tachycardia—Prednisolone—atopic dermatitis	5.15e-05	0.000481	CcSEcCtD
Aprepitant—Convulsion—Methylprednisolone—atopic dermatitis	5.14e-05	0.00048	CcSEcCtD
Aprepitant—Hypertension—Triamcinolone—atopic dermatitis	5.13e-05	0.000479	CcSEcCtD
Aprepitant—Hypertension—Methylprednisolone—atopic dermatitis	5.12e-05	0.000478	CcSEcCtD
Aprepitant—Infection—Hydrocortisone—atopic dermatitis	5.12e-05	0.000478	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisolone—atopic dermatitis	5.1e-05	0.000476	CcSEcCtD
Aprepitant—Shock—Hydrocortisone—atopic dermatitis	5.07e-05	0.000473	CcSEcCtD
Aprepitant—Myalgia—Triamcinolone—atopic dermatitis	5.06e-05	0.000473	CcSEcCtD
Aprepitant—Nervous system disorder—Hydrocortisone—atopic dermatitis	5.05e-05	0.000472	CcSEcCtD
Aprepitant—Arthralgia—Methylprednisolone—atopic dermatitis	5.05e-05	0.000471	CcSEcCtD
Aprepitant—Myalgia—Methylprednisolone—atopic dermatitis	5.05e-05	0.000471	CcSEcCtD
Aprepitant—Eye disorder—Prednisone—atopic dermatitis	5.04e-05	0.000471	CcSEcCtD
Aprepitant—Anxiety—Methylprednisolone—atopic dermatitis	5.03e-05	0.00047	CcSEcCtD
Aprepitant—Tachycardia—Hydrocortisone—atopic dermatitis	5.03e-05	0.00047	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.03e-05	0.00102	CbGpPWpGaD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	5.02e-05	0.000468	CcSEcCtD
Aprepitant—Flushing—Prednisone—atopic dermatitis	5.01e-05	0.000468	CcSEcCtD
Aprepitant—Skin disorder—Hydrocortisone—atopic dermatitis	5e-05	0.000467	CcSEcCtD
Aprepitant—Ill-defined disorder—Betamethasone—atopic dermatitis	5e-05	0.000467	CcSEcCtD
Aprepitant—Ill-defined disorder—Dexamethasone—atopic dermatitis	5e-05	0.000467	CcSEcCtD
Aprepitant—Discomfort—Triamcinolone—atopic dermatitis	5e-05	0.000467	CcSEcCtD
Aprepitant—Discomfort—Methylprednisolone—atopic dermatitis	4.99e-05	0.000466	CcSEcCtD
Aprepitant—Hyperhidrosis—Hydrocortisone—atopic dermatitis	4.98e-05	0.000465	CcSEcCtD
Aprepitant—Dry mouth—Triamcinolone—atopic dermatitis	4.95e-05	0.000462	CcSEcCtD
Aprepitant—Angioedema—Dexamethasone—atopic dermatitis	4.93e-05	0.00046	CcSEcCtD
Aprepitant—Angioedema—Betamethasone—atopic dermatitis	4.93e-05	0.00046	CcSEcCtD
Aprepitant—Anorexia—Hydrocortisone—atopic dermatitis	4.91e-05	0.000459	CcSEcCtD
Aprepitant—Nausea—Tacrolimus—atopic dermatitis	4.91e-05	0.000458	CcSEcCtD
Aprepitant—Angiopathy—Prednisone—atopic dermatitis	4.9e-05	0.000457	CcSEcCtD
Aprepitant—Confusional state—Methylprednisolone—atopic dermatitis	4.88e-05	0.000456	CcSEcCtD
Aprepitant—Immune system disorder—Prednisone—atopic dermatitis	4.87e-05	0.000455	CcSEcCtD
Aprepitant—Malaise—Dexamethasone—atopic dermatitis	4.86e-05	0.000454	CcSEcCtD
Aprepitant—Malaise—Betamethasone—atopic dermatitis	4.86e-05	0.000454	CcSEcCtD
Aprepitant—Oedema—Triamcinolone—atopic dermatitis	4.85e-05	0.000453	CcSEcCtD
Aprepitant—Anaphylactic shock—Triamcinolone—atopic dermatitis	4.85e-05	0.000453	CcSEcCtD
Aprepitant—Anaphylactic shock—Methylprednisolone—atopic dermatitis	4.84e-05	0.000452	CcSEcCtD
Aprepitant—Syncope—Dexamethasone—atopic dermatitis	4.84e-05	0.000452	CcSEcCtD
Aprepitant—Syncope—Betamethasone—atopic dermatitis	4.84e-05	0.000452	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—CXCL8—atopic dermatitis	4.83e-05	0.000977	CbGpPWpGaD
Aprepitant—Infection—Triamcinolone—atopic dermatitis	4.82e-05	0.00045	CcSEcCtD
Aprepitant—Hypotension—Hydrocortisone—atopic dermatitis	4.81e-05	0.00045	CcSEcCtD
Aprepitant—Infection—Methylprednisolone—atopic dermatitis	4.81e-05	0.000449	CcSEcCtD
Aprepitant—Shock—Triamcinolone—atopic dermatitis	4.77e-05	0.000446	CcSEcCtD
Aprepitant—Insomnia—Prednisolone—atopic dermatitis	4.77e-05	0.000446	CcSEcCtD
Aprepitant—Alopecia—Prednisone—atopic dermatitis	4.77e-05	0.000445	CcSEcCtD
Aprepitant—Shock—Methylprednisolone—atopic dermatitis	4.76e-05	0.000445	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—CCL5—atopic dermatitis	4.75e-05	0.000962	CbGpPWpGaD
Aprepitant—Nervous system disorder—Methylprednisolone—atopic dermatitis	4.75e-05	0.000443	CcSEcCtD
Aprepitant—Loss of consciousness—Dexamethasone—atopic dermatitis	4.74e-05	0.000443	CcSEcCtD
Aprepitant—Loss of consciousness—Betamethasone—atopic dermatitis	4.74e-05	0.000443	CcSEcCtD
Aprepitant—Paraesthesia—Prednisolone—atopic dermatitis	4.74e-05	0.000442	CcSEcCtD
Aprepitant—Tachycardia—Triamcinolone—atopic dermatitis	4.74e-05	0.000442	CcSEcCtD
Aprepitant—Mental disorder—Prednisone—atopic dermatitis	4.73e-05	0.000441	CcSEcCtD
Aprepitant—Tachycardia—Methylprednisolone—atopic dermatitis	4.72e-05	0.000441	CcSEcCtD
Aprepitant—Skin disorder—Methylprednisolone—atopic dermatitis	4.7e-05	0.000439	CcSEcCtD
Aprepitant—Malnutrition—Prednisone—atopic dermatitis	4.7e-05	0.000439	CcSEcCtD
Aprepitant—Erythema—Prednisone—atopic dermatitis	4.7e-05	0.000439	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	4.69e-05	0.000438	CcSEcCtD
Aprepitant—Hyperhidrosis—Triamcinolone—atopic dermatitis	4.69e-05	0.000438	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CCL11—atopic dermatitis	4.68e-05	0.000948	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CMA1—atopic dermatitis	4.68e-05	0.000948	CbGpPWpGaD
Aprepitant—Hyperhidrosis—Methylprednisolone—atopic dermatitis	4.68e-05	0.000437	CcSEcCtD
Aprepitant—Convulsion—Dexamethasone—atopic dermatitis	4.67e-05	0.000436	CcSEcCtD
Aprepitant—Convulsion—Betamethasone—atopic dermatitis	4.67e-05	0.000436	CcSEcCtD
Aprepitant—Insomnia—Hydrocortisone—atopic dermatitis	4.66e-05	0.000435	CcSEcCtD
Aprepitant—Hypertension—Betamethasone—atopic dermatitis	4.66e-05	0.000435	CcSEcCtD
Aprepitant—Hypertension—Dexamethasone—atopic dermatitis	4.66e-05	0.000435	CcSEcCtD
Aprepitant—Paraesthesia—Hydrocortisone—atopic dermatitis	4.63e-05	0.000432	CcSEcCtD
Aprepitant—TACR3—GPCR downstream signaling—IL2—atopic dermatitis	4.61e-05	0.000934	CbGpPWpGaD
Aprepitant—Myalgia—Dexamethasone—atopic dermatitis	4.59e-05	0.000429	CcSEcCtD
Aprepitant—Myalgia—Betamethasone—atopic dermatitis	4.59e-05	0.000429	CcSEcCtD
Aprepitant—Anxiety—Dexamethasone—atopic dermatitis	4.58e-05	0.000427	CcSEcCtD
Aprepitant—Anxiety—Betamethasone—atopic dermatitis	4.58e-05	0.000427	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—CXCL10—atopic dermatitis	4.56e-05	0.000924	CbGpPWpGaD
Aprepitant—Discomfort—Dexamethasone—atopic dermatitis	4.54e-05	0.000424	CcSEcCtD
Aprepitant—Discomfort—Betamethasone—atopic dermatitis	4.54e-05	0.000424	CcSEcCtD
Aprepitant—Dyspepsia—Hydrocortisone—atopic dermatitis	4.54e-05	0.000423	CcSEcCtD
Aprepitant—Hypotension—Methylprednisolone—atopic dermatitis	4.52e-05	0.000422	CcSEcCtD
Aprepitant—Pain—Prednisolone—atopic dermatitis	4.51e-05	0.000421	CcSEcCtD
Aprepitant—Decreased appetite—Hydrocortisone—atopic dermatitis	4.48e-05	0.000418	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	4.45e-05	0.000415	CcSEcCtD
Aprepitant—Fatigue—Hydrocortisone—atopic dermatitis	4.44e-05	0.000415	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	4.42e-05	0.000413	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	4.41e-05	0.000412	CcSEcCtD
Aprepitant—Pain—Hydrocortisone—atopic dermatitis	4.41e-05	0.000411	CcSEcCtD
Aprepitant—Oedema—Dexamethasone—atopic dermatitis	4.4e-05	0.000411	CcSEcCtD
Aprepitant—Anaphylactic shock—Betamethasone—atopic dermatitis	4.4e-05	0.000411	CcSEcCtD
Aprepitant—Anaphylactic shock—Dexamethasone—atopic dermatitis	4.4e-05	0.000411	CcSEcCtD
Aprepitant—Oedema—Betamethasone—atopic dermatitis	4.4e-05	0.000411	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—NGF—atopic dermatitis	4.4e-05	0.000891	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—STAT6—atopic dermatitis	4.4e-05	0.000891	CbGpPWpGaD
Aprepitant—Insomnia—Triamcinolone—atopic dermatitis	4.39e-05	0.00041	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—CXCL8—atopic dermatitis	4.38e-05	0.000887	CbGpPWpGaD
Aprepitant—Insomnia—Methylprednisolone—atopic dermatitis	4.38e-05	0.000409	CcSEcCtD
Aprepitant—Infection—Dexamethasone—atopic dermatitis	4.37e-05	0.000408	CcSEcCtD
Aprepitant—Infection—Betamethasone—atopic dermatitis	4.37e-05	0.000408	CcSEcCtD
Aprepitant—Ill-defined disorder—Prednisone—atopic dermatitis	4.36e-05	0.000407	CcSEcCtD
Aprepitant—Paraesthesia—Triamcinolone—atopic dermatitis	4.36e-05	0.000407	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisolone—atopic dermatitis	4.35e-05	0.000406	CcSEcCtD
Aprepitant—Paraesthesia—Methylprednisolone—atopic dermatitis	4.35e-05	0.000406	CcSEcCtD
Aprepitant—Anaemia—Prednisone—atopic dermatitis	4.34e-05	0.000405	CcSEcCtD
Aprepitant—Shock—Betamethasone—atopic dermatitis	4.33e-05	0.000404	CcSEcCtD
Aprepitant—Shock—Dexamethasone—atopic dermatitis	4.33e-05	0.000404	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—CCL5—atopic dermatitis	4.33e-05	0.000876	CbGpPWpGaD
Aprepitant—Dyspnoea—Triamcinolone—atopic dermatitis	4.33e-05	0.000404	CcSEcCtD
Aprepitant—Nervous system disorder—Dexamethasone—atopic dermatitis	4.32e-05	0.000403	CcSEcCtD
Aprepitant—Nervous system disorder—Betamethasone—atopic dermatitis	4.32e-05	0.000403	CcSEcCtD
Aprepitant—Thrombocytopenia—Betamethasone—atopic dermatitis	4.31e-05	0.000402	CcSEcCtD
Aprepitant—Thrombocytopenia—Dexamethasone—atopic dermatitis	4.31e-05	0.000402	CcSEcCtD
Aprepitant—Tachycardia—Dexamethasone—atopic dermatitis	4.3e-05	0.000401	CcSEcCtD
Aprepitant—Tachycardia—Betamethasone—atopic dermatitis	4.3e-05	0.000401	CcSEcCtD
Aprepitant—Angioedema—Prednisone—atopic dermatitis	4.29e-05	0.000401	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—CCR5—atopic dermatitis	4.28e-05	0.000867	CbGpPWpGaD
Aprepitant—Dyspepsia—Triamcinolone—atopic dermatitis	4.27e-05	0.000399	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	4.27e-05	0.000864	CbGpPWpGaD
Aprepitant—Dyspepsia—Methylprednisolone—atopic dermatitis	4.26e-05	0.000398	CcSEcCtD
Aprepitant—Hyperhidrosis—Dexamethasone—atopic dermatitis	4.26e-05	0.000397	CcSEcCtD
Aprepitant—Hyperhidrosis—Betamethasone—atopic dermatitis	4.26e-05	0.000397	CcSEcCtD
Aprepitant—Feeling abnormal—Hydrocortisone—atopic dermatitis	4.25e-05	0.000396	CcSEcCtD
Aprepitant—Malaise—Prednisone—atopic dermatitis	4.24e-05	0.000396	CcSEcCtD
Aprepitant—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	4.21e-05	0.000393	CcSEcCtD
Aprepitant—Syncope—Prednisone—atopic dermatitis	4.21e-05	0.000393	CcSEcCtD
Aprepitant—Anorexia—Dexamethasone—atopic dermatitis	4.2e-05	0.000392	CcSEcCtD
Aprepitant—Anorexia—Betamethasone—atopic dermatitis	4.2e-05	0.000392	CcSEcCtD
Aprepitant—Urticaria—Prednisolone—atopic dermatitis	4.19e-05	0.000391	CcSEcCtD
Aprepitant—TACR3—Signaling by GPCR—IL2—atopic dermatitis	4.19e-05	0.000848	CbGpPWpGaD
Aprepitant—Fatigue—Triamcinolone—atopic dermatitis	4.18e-05	0.000391	CcSEcCtD
Aprepitant—Fatigue—Methylprednisolone—atopic dermatitis	4.17e-05	0.00039	CcSEcCtD
Aprepitant—TACR1—GPCR ligand binding—CXCL8—atopic dermatitis	4.17e-05	0.000844	CbGpPWpGaD
Aprepitant—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	4.15e-05	0.000841	CbGpPWpGaD
Aprepitant—Pain—Triamcinolone—atopic dermatitis	4.15e-05	0.000387	CcSEcCtD
Aprepitant—Loss of consciousness—Prednisone—atopic dermatitis	4.13e-05	0.000385	CcSEcCtD
Aprepitant—Hypotension—Dexamethasone—atopic dermatitis	4.11e-05	0.000384	CcSEcCtD
Aprepitant—Hypotension—Betamethasone—atopic dermatitis	4.11e-05	0.000384	CcSEcCtD
Aprepitant—Urticaria—Hydrocortisone—atopic dermatitis	4.09e-05	0.000382	CcSEcCtD
Aprepitant—Body temperature increased—Hydrocortisone—atopic dermatitis	4.07e-05	0.00038	CcSEcCtD
Aprepitant—Abdominal pain—Hydrocortisone—atopic dermatitis	4.07e-05	0.00038	CcSEcCtD
Aprepitant—Convulsion—Prednisone—atopic dermatitis	4.07e-05	0.00038	CcSEcCtD
Aprepitant—Hypertension—Prednisone—atopic dermatitis	4.06e-05	0.000379	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	4.01e-05	0.000374	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	4.01e-05	0.000374	CcSEcCtD
Aprepitant—Arthralgia—Prednisone—atopic dermatitis	4e-05	0.000373	CcSEcCtD
Aprepitant—Myalgia—Prednisone—atopic dermatitis	4e-05	0.000373	CcSEcCtD
Aprepitant—Feeling abnormal—Triamcinolone—atopic dermatitis	4e-05	0.000373	CcSEcCtD
Aprepitant—Feeling abnormal—Methylprednisolone—atopic dermatitis	3.99e-05	0.000372	CcSEcCtD
Aprepitant—Anxiety—Prednisone—atopic dermatitis	3.99e-05	0.000372	CcSEcCtD
Aprepitant—Insomnia—Dexamethasone—atopic dermatitis	3.98e-05	0.000372	CcSEcCtD
Aprepitant—Insomnia—Betamethasone—atopic dermatitis	3.98e-05	0.000372	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	3.97e-05	0.000371	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	3.96e-05	0.00037	CcSEcCtD
Aprepitant—Paraesthesia—Dexamethasone—atopic dermatitis	3.95e-05	0.000369	CcSEcCtD
Aprepitant—Paraesthesia—Betamethasone—atopic dermatitis	3.95e-05	0.000369	CcSEcCtD
Aprepitant—Discomfort—Prednisone—atopic dermatitis	3.95e-05	0.000369	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—CCL5—atopic dermatitis	3.93e-05	0.000795	CbGpPWpGaD
Aprepitant—TACR1—GPCR downstream signaling—CCR5—atopic dermatitis	3.9e-05	0.000789	CbGpPWpGaD
Aprepitant—Hypersensitivity—Prednisolone—atopic dermatitis	3.89e-05	0.000363	CcSEcCtD
Aprepitant—Dyspepsia—Dexamethasone—atopic dermatitis	3.88e-05	0.000362	CcSEcCtD
Aprepitant—Dyspepsia—Betamethasone—atopic dermatitis	3.88e-05	0.000362	CcSEcCtD
Aprepitant—Urticaria—Triamcinolone—atopic dermatitis	3.85e-05	0.00036	CcSEcCtD
Aprepitant—Urticaria—Methylprednisolone—atopic dermatitis	3.85e-05	0.000359	CcSEcCtD
Aprepitant—Body temperature increased—Triamcinolone—atopic dermatitis	3.84e-05	0.000358	CcSEcCtD
Aprepitant—Oedema—Prednisone—atopic dermatitis	3.83e-05	0.000358	CcSEcCtD
Aprepitant—Anaphylactic shock—Prednisone—atopic dermatitis	3.83e-05	0.000358	CcSEcCtD
Aprepitant—Abdominal pain—Methylprednisolone—atopic dermatitis	3.83e-05	0.000357	CcSEcCtD
Aprepitant—Decreased appetite—Dexamethasone—atopic dermatitis	3.83e-05	0.000357	CcSEcCtD
Aprepitant—Decreased appetite—Betamethasone—atopic dermatitis	3.83e-05	0.000357	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CCR3—atopic dermatitis	3.82e-05	0.000773	CbGpPWpGaD
Aprepitant—Infection—Prednisone—atopic dermatitis	3.81e-05	0.000356	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	3.81e-05	0.000771	CbGpPWpGaD
Aprepitant—Gastrointestinal disorder—Betamethasone—atopic dermatitis	3.8e-05	0.000355	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	3.8e-05	0.000355	CcSEcCtD
Aprepitant—Hypersensitivity—Hydrocortisone—atopic dermatitis	3.8e-05	0.000354	CcSEcCtD
Aprepitant—Fatigue—Dexamethasone—atopic dermatitis	3.8e-05	0.000354	CcSEcCtD
Aprepitant—Fatigue—Betamethasone—atopic dermatitis	3.8e-05	0.000354	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	3.79e-05	0.000768	CbGpPWpGaD
Aprepitant—Shock—Prednisone—atopic dermatitis	3.77e-05	0.000352	CcSEcCtD
Aprepitant—Pain—Dexamethasone—atopic dermatitis	3.76e-05	0.000351	CcSEcCtD
Aprepitant—Pain—Betamethasone—atopic dermatitis	3.76e-05	0.000351	CcSEcCtD
Aprepitant—Nervous system disorder—Prednisone—atopic dermatitis	3.76e-05	0.000351	CcSEcCtD
Aprepitant—Tachycardia—Prednisone—atopic dermatitis	3.74e-05	0.000349	CcSEcCtD
Aprepitant—Skin disorder—Prednisone—atopic dermatitis	3.72e-05	0.000348	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisone—atopic dermatitis	3.71e-05	0.000346	CcSEcCtD
Aprepitant—Asthenia—Hydrocortisone—atopic dermatitis	3.7e-05	0.000345	CcSEcCtD
Aprepitant—Anorexia—Prednisone—atopic dermatitis	3.65e-05	0.000341	CcSEcCtD
Aprepitant—Pruritus—Hydrocortisone—atopic dermatitis	3.65e-05	0.00034	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—NFKBIA—atopic dermatitis	3.63e-05	0.000735	CbGpPWpGaD
Aprepitant—Feeling abnormal—Betamethasone—atopic dermatitis	3.63e-05	0.000339	CcSEcCtD
Aprepitant—Feeling abnormal—Dexamethasone—atopic dermatitis	3.63e-05	0.000339	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dexamethasone—atopic dermatitis	3.6e-05	0.000336	CcSEcCtD
Aprepitant—Gastrointestinal pain—Betamethasone—atopic dermatitis	3.6e-05	0.000336	CcSEcCtD
Aprepitant—Hypersensitivity—Triamcinolone—atopic dermatitis	3.57e-05	0.000334	CcSEcCtD
Aprepitant—Hypersensitivity—Methylprednisolone—atopic dermatitis	3.57e-05	0.000333	CcSEcCtD
Aprepitant—TACR1—Signaling by GPCR—CCR5—atopic dermatitis	3.54e-05	0.000717	CbGpPWpGaD
Aprepitant—Diarrhoea—Hydrocortisone—atopic dermatitis	3.53e-05	0.000329	CcSEcCtD
Aprepitant—Urticaria—Dexamethasone—atopic dermatitis	3.5e-05	0.000327	CcSEcCtD
Aprepitant—Urticaria—Betamethasone—atopic dermatitis	3.5e-05	0.000327	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Prednisone—atopic dermatitis	3.49e-05	0.000326	CcSEcCtD
Aprepitant—Dizziness—Prednisolone—atopic dermatitis	3.49e-05	0.000326	CcSEcCtD
Aprepitant—Asthenia—Triamcinolone—atopic dermatitis	3.48e-05	0.000325	CcSEcCtD
Aprepitant—Abdominal pain—Dexamethasone—atopic dermatitis	3.48e-05	0.000325	CcSEcCtD
Aprepitant—Body temperature increased—Dexamethasone—atopic dermatitis	3.48e-05	0.000325	CcSEcCtD
Aprepitant—Body temperature increased—Betamethasone—atopic dermatitis	3.48e-05	0.000325	CcSEcCtD
Aprepitant—Abdominal pain—Betamethasone—atopic dermatitis	3.48e-05	0.000325	CcSEcCtD
Aprepitant—Asthenia—Methylprednisolone—atopic dermatitis	3.47e-05	0.000324	CcSEcCtD
Aprepitant—Insomnia—Prednisone—atopic dermatitis	3.47e-05	0.000324	CcSEcCtD
Aprepitant—Paraesthesia—Prednisone—atopic dermatitis	3.44e-05	0.000321	CcSEcCtD
Aprepitant—Pruritus—Triamcinolone—atopic dermatitis	3.43e-05	0.00032	CcSEcCtD
Aprepitant—Pruritus—Methylprednisolone—atopic dermatitis	3.42e-05	0.00032	CcSEcCtD
Aprepitant—Dizziness—Hydrocortisone—atopic dermatitis	3.41e-05	0.000318	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—NPS—atopic dermatitis	3.4e-05	0.000689	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—TAC1—atopic dermatitis	3.4e-05	0.000689	CbGpPWpGaD
Aprepitant—Dyspepsia—Prednisone—atopic dermatitis	3.37e-05	0.000315	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CXCR3—atopic dermatitis	3.34e-05	0.000675	CbGpPWpGaD
Aprepitant—Decreased appetite—Prednisone—atopic dermatitis	3.33e-05	0.000311	CcSEcCtD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.33e-05	0.000674	CbGpPWpGaD
Aprepitant—Rash—Prednisolone—atopic dermatitis	3.33e-05	0.000311	CcSEcCtD
Aprepitant—Dermatitis—Prednisolone—atopic dermatitis	3.32e-05	0.00031	CcSEcCtD
Aprepitant—Diarrhoea—Methylprednisolone—atopic dermatitis	3.31e-05	0.000309	CcSEcCtD
Aprepitant—Fatigue—Prednisone—atopic dermatitis	3.31e-05	0.000309	CcSEcCtD
Aprepitant—Headache—Prednisolone—atopic dermatitis	3.31e-05	0.000309	CcSEcCtD
Aprepitant—Constipation—Prednisone—atopic dermatitis	3.28e-05	0.000306	CcSEcCtD
Aprepitant—Vomiting—Hydrocortisone—atopic dermatitis	3.28e-05	0.000306	CcSEcCtD
Aprepitant—Rash—Hydrocortisone—atopic dermatitis	3.25e-05	0.000303	CcSEcCtD
Aprepitant—Dermatitis—Hydrocortisone—atopic dermatitis	3.25e-05	0.000303	CcSEcCtD
Aprepitant—Headache—Hydrocortisone—atopic dermatitis	3.23e-05	0.000301	CcSEcCtD
Aprepitant—Dizziness—Triamcinolone—atopic dermatitis	3.21e-05	0.0003	CcSEcCtD
Aprepitant—Dizziness—Methylprednisolone—atopic dermatitis	3.2e-05	0.000299	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—IL5—atopic dermatitis	3.16e-05	0.00064	CbGpPWpGaD
Aprepitant—Feeling abnormal—Prednisone—atopic dermatitis	3.16e-05	0.000295	CcSEcCtD
Aprepitant—Asthenia—Dexamethasone—atopic dermatitis	3.16e-05	0.000295	CcSEcCtD
Aprepitant—Asthenia—Betamethasone—atopic dermatitis	3.16e-05	0.000295	CcSEcCtD
Aprepitant—Gastrointestinal pain—Prednisone—atopic dermatitis	3.14e-05	0.000293	CcSEcCtD
Aprepitant—Nausea—Prednisolone—atopic dermatitis	3.13e-05	0.000293	CcSEcCtD
Aprepitant—Pruritus—Dexamethasone—atopic dermatitis	3.11e-05	0.000291	CcSEcCtD
Aprepitant—Pruritus—Betamethasone—atopic dermatitis	3.11e-05	0.000291	CcSEcCtD
Aprepitant—Vomiting—Triamcinolone—atopic dermatitis	3.08e-05	0.000288	CcSEcCtD
Aprepitant—Vomiting—Methylprednisolone—atopic dermatitis	3.08e-05	0.000287	CcSEcCtD
Aprepitant—Nausea—Hydrocortisone—atopic dermatitis	3.06e-05	0.000286	CcSEcCtD
Aprepitant—Rash—Triamcinolone—atopic dermatitis	3.06e-05	0.000286	CcSEcCtD
Aprepitant—Dermatitis—Triamcinolone—atopic dermatitis	3.06e-05	0.000285	CcSEcCtD
Aprepitant—Rash—Methylprednisolone—atopic dermatitis	3.05e-05	0.000285	CcSEcCtD
Aprepitant—Dermatitis—Methylprednisolone—atopic dermatitis	3.05e-05	0.000285	CcSEcCtD
Aprepitant—Urticaria—Prednisone—atopic dermatitis	3.05e-05	0.000284	CcSEcCtD
Aprepitant—Headache—Triamcinolone—atopic dermatitis	3.04e-05	0.000284	CcSEcCtD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.03e-05	0.000614	CbGpPWpGaD
Aprepitant—Headache—Methylprednisolone—atopic dermatitis	3.03e-05	0.000283	CcSEcCtD
Aprepitant—Body temperature increased—Prednisone—atopic dermatitis	3.03e-05	0.000283	CcSEcCtD
Aprepitant—Abdominal pain—Prednisone—atopic dermatitis	3.03e-05	0.000283	CcSEcCtD
Aprepitant—Diarrhoea—Dexamethasone—atopic dermatitis	3.01e-05	0.000281	CcSEcCtD
Aprepitant—Diarrhoea—Betamethasone—atopic dermatitis	3.01e-05	0.000281	CcSEcCtD
Aprepitant—Dizziness—Dexamethasone—atopic dermatitis	2.91e-05	0.000272	CcSEcCtD
Aprepitant—Dizziness—Betamethasone—atopic dermatitis	2.91e-05	0.000272	CcSEcCtD
Aprepitant—Nausea—Triamcinolone—atopic dermatitis	2.88e-05	0.000269	CcSEcCtD
Aprepitant—Nausea—Methylprednisolone—atopic dermatitis	2.88e-05	0.000268	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisone—atopic dermatitis	2.82e-05	0.000264	CcSEcCtD
Aprepitant—Vomiting—Dexamethasone—atopic dermatitis	2.8e-05	0.000261	CcSEcCtD
Aprepitant—Vomiting—Betamethasone—atopic dermatitis	2.8e-05	0.000261	CcSEcCtD
Aprepitant—Rash—Betamethasone—atopic dermatitis	2.78e-05	0.000259	CcSEcCtD
Aprepitant—Rash—Dexamethasone—atopic dermatitis	2.78e-05	0.000259	CcSEcCtD
Aprepitant—Dermatitis—Betamethasone—atopic dermatitis	2.77e-05	0.000259	CcSEcCtD
Aprepitant—Dermatitis—Dexamethasone—atopic dermatitis	2.77e-05	0.000259	CcSEcCtD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	2.76e-05	0.000559	CbGpPWpGaD
Aprepitant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	2.76e-05	0.000559	CbGpPWpGaD
Aprepitant—Headache—Betamethasone—atopic dermatitis	2.76e-05	0.000257	CcSEcCtD
Aprepitant—Headache—Dexamethasone—atopic dermatitis	2.76e-05	0.000257	CcSEcCtD
Aprepitant—Asthenia—Prednisone—atopic dermatitis	2.75e-05	0.000257	CcSEcCtD
Aprepitant—Pruritus—Prednisone—atopic dermatitis	2.71e-05	0.000253	CcSEcCtD
Aprepitant—TACR1—Signaling Pathways—CXCL10—atopic dermatitis	2.7e-05	0.000546	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—GLB1—atopic dermatitis	2.65e-05	0.000537	CbGpPWpGaD
Aprepitant—Diarrhoea—Prednisone—atopic dermatitis	2.62e-05	0.000245	CcSEcCtD
Aprepitant—Nausea—Betamethasone—atopic dermatitis	2.61e-05	0.000244	CcSEcCtD
Aprepitant—Nausea—Dexamethasone—atopic dermatitis	2.61e-05	0.000244	CcSEcCtD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.59e-05	0.000525	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—CXCL8—atopic dermatitis	2.59e-05	0.000524	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—ADSL—atopic dermatitis	2.54e-05	0.000515	CbGpPWpGaD
Aprepitant—Dizziness—Prednisone—atopic dermatitis	2.54e-05	0.000237	CcSEcCtD
Aprepitant—TACR3—Signaling Pathways—IL2—atopic dermatitis	2.47e-05	0.000501	CbGpPWpGaD
Aprepitant—TACR3—Signaling by GPCR—IL6—atopic dermatitis	2.46e-05	0.000498	CbGpPWpGaD
Aprepitant—Vomiting—Prednisone—atopic dermatitis	2.44e-05	0.000228	CcSEcCtD
Aprepitant—Rash—Prednisone—atopic dermatitis	2.42e-05	0.000226	CcSEcCtD
Aprepitant—Dermatitis—Prednisone—atopic dermatitis	2.42e-05	0.000225	CcSEcCtD
Aprepitant—Headache—Prednisone—atopic dermatitis	2.4e-05	0.000224	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.36e-05	0.000477	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCL5—atopic dermatitis	2.32e-05	0.00047	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—MAPK8—atopic dermatitis	2.28e-05	0.000461	CbGpPWpGaD
Aprepitant—Nausea—Prednisone—atopic dermatitis	2.28e-05	0.000213	CcSEcCtD
Aprepitant—TACR1—GPCR downstream signaling—IL2—atopic dermatitis	2.25e-05	0.000456	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NGF—atopic dermatitis	2.15e-05	0.000435	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—CXCL8—atopic dermatitis	2.14e-05	0.000433	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CCR5—atopic dermatitis	2.09e-05	0.000423	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL2—atopic dermatitis	2.05e-05	0.000414	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—GLB1—atopic dermatitis	1.92e-05	0.000388	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—ADSL—atopic dermatitis	1.84e-05	0.000372	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—NFKBIA—atopic dermatitis	1.77e-05	0.000359	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—GLB1—atopic dermatitis	1.48e-05	0.0003	CbGpPWpGaD
Aprepitant—TACR3—Signaling Pathways—IL6—atopic dermatitis	1.45e-05	0.000294	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—ADSL—atopic dermatitis	1.42e-05	0.000288	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—GLB1—atopic dermatitis	1.35e-05	0.000274	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—ADSL—atopic dermatitis	1.3e-05	0.000262	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—CXCL8—atopic dermatitis	1.26e-05	0.000256	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL2—atopic dermatitis	1.21e-05	0.000245	CbGpPWpGaD
Aprepitant—TACR1—Signaling by GPCR—IL6—atopic dermatitis	1.2e-05	0.000243	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.15e-05	0.000234	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—MAPK8—atopic dermatitis	1.11e-05	0.000225	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.11e-05	0.000224	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.08e-05	0.000219	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.85e-06	0.000199	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—GLB1—atopic dermatitis	8.91e-06	0.00018	CbGpPWpGaD
Aprepitant—CYP3A7—Metabolism—PPARA—atopic dermatitis	8.61e-06	0.000174	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—ADSL—atopic dermatitis	8.55e-06	0.000173	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	8.42e-06	0.00017	CbGpPWpGaD
Aprepitant—TACR1—Signaling Pathways—IL6—atopic dermatitis	7.1e-06	0.000144	CbGpPWpGaD
Aprepitant—CYP3A5—Metabolism—PPARA—atopic dermatitis	6.22e-06	0.000126	CbGpPWpGaD
Aprepitant—CYP2C19—Metabolism—PPARA—atopic dermatitis	4.81e-06	9.74e-05	CbGpPWpGaD
Aprepitant—CYP2C9—Metabolism—PPARA—atopic dermatitis	4.39e-06	8.88e-05	CbGpPWpGaD
Aprepitant—CYP1A2—Metabolism—PPARA—atopic dermatitis	3.75e-06	7.59e-05	CbGpPWpGaD
Aprepitant—CYP3A4—Metabolism—PPARA—atopic dermatitis	2.89e-06	5.86e-05	CbGpPWpGaD
